Skip to main content

OrthoPediatrics Corp. Announces First PNP|FEMUR Case Performed in the United Kingdom

Written by Customer Service on . Posted in Public Companies.

WARSAW, Ind., Dec. 29, 2020 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced the first surgery in the United Kingdom utilizing the new Pediatric Nailing Platform | FEMUR (“PNP|FEMUR”).
Representing a significant new option for certain anatomies, the PNP|FEMUR system is designed for use in pediatric and small stature adult patients to address femoral fractures or deformity correction procedures. The system launched in the United States in 2018 and is available in the U.K. markets as of this month.The first case was performed at Sheffield Children’s Hospital by James Fernandes, Consultant Orthopaedic Surgeon. Mr. Fernandes commented, “The new PNP nail is quite advanced and versatile with interesting newer instrumentation elements that will be very handy to the surgeon, especially with difficult and complex cases.”Joe Hauser, OrthoPediatrics’ Senior Vice President of Trauma & Deformity Correction, stated, “We are extremely pleased to introduce the PNP|FEMUR system to surgeons in the U.K. Our commitment to continuous improvement and innovation in pediatric orthopedics is best represented in the launch of our 3rd generation nailing system, which was built on the shoulders of the original PediNail from over 8 years and 6,000+ cases of global surgeon feedback and experience. This new system has graduated to treat unique pediatric and adolescent anatomies and we are delighted to hear the first case in the U.K. was a great success! We look forward to helping many more children with this technology.”About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit www.orthopediatrics.com.Investor Contact
The Ruth Group
Jan Medina, CFA
(646) 536-7035
jmedina@theruthgroup.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.